S6UQ.F · Liberty Health Sciences Inc

-

Please sign in to comment on S6UQ.F

1 Comment

Admin

4 years, 1 month ago

Liberty Health Sciences Inc is currently in a long term uptrend where the price is trading 89.6% above its 200 day moving average.

From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.4.

Liberty Health Sciences Inc's total revenue sank by 19.1% to $13M since the same quarter in the previous year.

Its net income has dropped by 130.6% to $-2M since the same quarter in the previous year.

Finally, its free cash flow fell by 136.6% to $-2M since the same quarter in the previous year.

Based on the above factors, Liberty Health Sciences Inc gets an overall score of 2/5.

Exchange	F
CurrencyCode	EUR
ISIN	None
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

PE Ratio	14.13
Target Price	None
Dividend Yield	0.0%
Market Cap	327M
Beta	1.52

ABOUT

Liberty Health Sciences Inc

Liberty Health Sciences Inc. engages in the production and distribution of medical cannabis in the United States. The company offers medical cannabis in the State of Florida through the Florida Department of Health, office of medical marijuana use. As of February 24, 2021, it operated 31 dispensaries in Florida. The company is headquartered in Gainesville, Florida. As of February 26, 2021, Liberty Health Sciences Inc. operates as a subsidiary of Ayr Wellness Inc.

S6UQ.F · Liberty Health Sciences Inc

-

Liberty Health Sciences Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Liberty Health Sciences Inc using a moving average strategy